Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Kallenberg

Showing results (31-40 of 267) with videos related to

Pageof 27
Sort By:
Springer Seminars in Immunopathology|October 10, 2001
Clinical aspects of primary vasculitisC A Stegeman, C G Kallenberg
Annals of the Rheumatic Diseases|October 29, 2000
What is new in systemic vasculitis?C G Kallenberg, J W Tervaert
Nederlands Tijdschrift Voor Geneeskunde|July 14, 1979
[Agranulocytosis caused by niflumic acid (Infaryl)]C G Kallenberg, H W Roenhorst
Journal of Neurology|July 1, 1993
Anti-myeloperoxidase antibodies in Churg-Strauss syndromeJ W Tervaert, C G Kallenberg
Clinical Rheumatology|June 1, 1987
Antinuclear antibody (ANA) substrates and quantification techniquesC G Kallenberg, P C Limburg
The American Review of Respiratory Disease|March 1, 1987
Anti-cytoplasmatic antibody in Wegener's granulomatosisJ W Tervaert, C G Kallenberg
Clinical Nephrology|February 1, 1993
Positive ANCA and diagnosis of systemic vasculitisC G Kallenberg, J W Tervaert
The Journal of Rheumatology|September 1, 1992
Nailfold capillary density as a possible indicator of pulmonary capillary loss in SLE but not in mixed connective tissue diseaseP M Houtman, C G Kallenberg
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|August 25, 2000
New treatments of ANCA-associated vasculitisC G Kallenberg, J W Tervaert
Current Opinion in Rheumatology|January 1, 1997
Cell adhesion molecules in vasculitisJ W Tervaert, C G Kallenberg
Pageof 27

Showing results (31-40 of 267) with videos related to

Sort By:
Pageof 27
Springer Seminars in Immunopathology|October 10, 2001
Clinical aspects of primary vasculitisC A Stegeman, C G Kallenberg
Annals of the Rheumatic Diseases|October 29, 2000
What is new in systemic vasculitis?C G Kallenberg, J W Tervaert
Nederlands Tijdschrift Voor Geneeskunde|July 14, 1979
[Agranulocytosis caused by niflumic acid (Infaryl)]C G Kallenberg, H W Roenhorst
Journal of Neurology|July 1, 1993
Anti-myeloperoxidase antibodies in Churg-Strauss syndromeJ W Tervaert, C G Kallenberg
Clinical Rheumatology|June 1, 1987
Antinuclear antibody (ANA) substrates and quantification techniquesC G Kallenberg, P C Limburg
The American Review of Respiratory Disease|March 1, 1987
Anti-cytoplasmatic antibody in Wegener's granulomatosisJ W Tervaert, C G Kallenberg
Clinical Nephrology|February 1, 1993
Positive ANCA and diagnosis of systemic vasculitisC G Kallenberg, J W Tervaert
The Journal of Rheumatology|September 1, 1992
Nailfold capillary density as a possible indicator of pulmonary capillary loss in SLE but not in mixed connective tissue diseaseP M Houtman, C G Kallenberg
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|August 25, 2000
New treatments of ANCA-associated vasculitisC G Kallenberg, J W Tervaert
Current Opinion in Rheumatology|January 1, 1997
Cell adhesion molecules in vasculitisJ W Tervaert, C G Kallenberg
Pageof 27